Our July newsletter hit the stands ⚡🧪
💡 From PhD to Start-Up
🔦 Spotlights on bit.bio & Medicilon
📰 News & events
👋 Welcome: Apexomic; Curve; deepmirror; Inspiralis; Kuano; LSG; Standard BioTools; Vector Bioscience Cambridge
🔗https://mailchi.mp/milner.cam.ac.uk/milner-newsletter-july-25
💡 From PhD to Start-Up
🔦 Spotlights on bit.bio & Medicilon
📰 News & events
👋 Welcome: Apexomic; Curve; deepmirror; Inspiralis; Kuano; LSG; Standard BioTools; Vector Bioscience Cambridge
🔗https://mailchi.mp/milner.cam.ac.uk/milner-newsletter-july-25
July 24, 2025 at 12:47 PM
Our July newsletter hit the stands ⚡🧪
💡 From PhD to Start-Up
🔦 Spotlights on bit.bio & Medicilon
📰 News & events
👋 Welcome: Apexomic; Curve; deepmirror; Inspiralis; Kuano; LSG; Standard BioTools; Vector Bioscience Cambridge
🔗https://mailchi.mp/milner.cam.ac.uk/milner-newsletter-july-25
💡 From PhD to Start-Up
🔦 Spotlights on bit.bio & Medicilon
📰 News & events
👋 Welcome: Apexomic; Curve; deepmirror; Inspiralis; Kuano; LSG; Standard BioTools; Vector Bioscience Cambridge
🔗https://mailchi.mp/milner.cam.ac.uk/milner-newsletter-july-25
[1/2] 2026-04-29 18:32:55 - [Medicilon: Net profit in the first quarter is 15.6154 million yuan] Medicilon announced that revenue in the first quarter of 2026 was 365 million yuan, compared with 267 million yuan in the same period last year;
April 29, 2026 at 10:42 AM
[1/2] 2026-04-29 18:32:55 - [Medicilon: Net profit in the first quarter is 15.6154 million yuan] Medicilon announced that revenue in the first quarter of 2026 was 365 million yuan, compared with 267 million yuan in the same period last year;
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
July 9, 2026 at 2:12 AM
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
July 9, 2026 at 2:13 AM
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
2026-07-22 09:39:05 - [Generic drug concept stocks moved up, Medicilon rose more than 6%] Generic drug concept stocks moved up, Medicilon rose more than 6%, Harbin Pharmaceutical Co., Ltd., Zhongsheng Pharmaceutical, Hainan Haiyang and other stocks rose one after another.
July 22, 2026 at 1:47 AM
2026-07-22 09:39:05 - [Generic drug concept stocks moved up, Medicilon rose more than 6%] Generic drug concept stocks moved up, Medicilon rose more than 6%, Harbin Pharmaceutical Co., Ltd., Zhongsheng Pharmaceutical, Hainan Haiyang and other stocks rose one after another.
2026-07-22 09:39:05 - [Generic drug concept stocks moved up, Medicilon rose more than 6%] Generic drug concept stocks moved up, Medicilon rose more than 6%, Harbin Pharmaceutical Co., Ltd., Zhongsheng Pharmaceutical, Hainan Haiyang and other stocks rose one after another.
July 22, 2026 at 1:48 AM
2026-07-22 09:39:05 - [Generic drug concept stocks moved up, Medicilon rose more than 6%] Generic drug concept stocks moved up, Medicilon rose more than 6%, Harbin Pharmaceutical Co., Ltd., Zhongsheng Pharmaceutical, Hainan Haiyang and other stocks rose one after another.
2026-07-22 09:39:05 - [Generic drug concept stocks moved up, Medicilon rose more than 6%] Generic drug concept stocks moved up, Medicilon rose more than 6%, Harbin Pharmaceutical Co., Ltd., Zhongsheng Pharmaceutical, Hainan Haiyang and other stocks rose one after another.
July 22, 2026 at 1:48 AM
2026-07-22 09:39:05 - [Generic drug concept stocks moved up, Medicilon rose more than 6%] Generic drug concept stocks moved up, Medicilon rose more than 6%, Harbin Pharmaceutical Co., Ltd., Zhongsheng Pharmaceutical, Hainan Haiyang and other stocks rose one after another.
[1/4] 2026-07-19 22:11:25 - [Medicil: Net profit will turn from loss to profit in the first half of 2026 Year-on-year growth of 425.62%-588.43%] Medicilon announced that it expects the net profit attributable to the owners of the parent company to be 42 million yuan to 63 million yuan
July 19, 2026 at 2:22 PM
[1/4] 2026-07-19 22:11:25 - [Medicil: Net profit will turn from loss to profit in the first half of 2026 Year-on-year growth of 425.62%-588.43%] Medicilon announced that it expects the net profit attributable to the owners of the parent company to be 42 million yuan to 63 million yuan
[2/6] "monkey" concept stocks such as Medicilon, Pharmaron, and WuXi AppTec fell one after another. It is worth noting that after the "monkey" concept became popular, many netizens hyped the experimental monkey as a "monkey module", called Mount Emei "monkey storage", and even made up
July 17, 2026 at 1:49 PM
[2/6] "monkey" concept stocks such as Medicilon, Pharmaron, and WuXi AppTec fell one after another. It is worth noting that after the "monkey" concept became popular, many netizens hyped the experimental monkey as a "monkey module", called Mount Emei "monkey storage", and even made up
[2/6] "monkey" concept stocks such as Medicilon, Pharmaron, and WuXi AppTec fell one after another. It is worth noting that after the "monkey" concept became popular, many netizens hyped the experimental monkey as a "monkey module", called Mount Emei "monkey storage", and even made up
July 17, 2026 at 1:47 PM
[2/6] "monkey" concept stocks such as Medicilon, Pharmaron, and WuXi AppTec fell one after another. It is worth noting that after the "monkey" concept became popular, many netizens hyped the experimental monkey as a "monkey module", called Mount Emei "monkey storage", and even made up
[2/6] "monkey" concept stocks such as Medicilon, Pharmaron, and WuXi AppTec fell one after another. It is worth noting that after the "monkey" concept became popular, many netizens hyped the experimental monkey as a "monkey module", called Mount Emei "monkey storage", and even made up
July 17, 2026 at 1:47 PM
[2/6] "monkey" concept stocks such as Medicilon, Pharmaron, and WuXi AppTec fell one after another. It is worth noting that after the "monkey" concept became popular, many netizens hyped the experimental monkey as a "monkey module", called Mount Emei "monkey storage", and even made up
[1/4] 2026-07-13 16:37:19 - [Medicil: Shareholder Lin Changqing and persons acting in concert have reduced their holdings by more than 1%] Medicilon announced that as of July 10, 2026, shareholder Lin Changqing had reduced its holdings of 240,000 shares of the company through
July 13, 2026 at 8:56 AM
[1/4] 2026-07-13 16:37:19 - [Medicil: Shareholder Lin Changqing and persons acting in concert have reduced their holdings by more than 1%] Medicilon announced that as of July 10, 2026, shareholder Lin Changqing had reduced its holdings of 240,000 shares of the company through
[1/4] 2026-07-13 16:37:19 - [Medicil: Shareholder Lin Changqing and persons acting in concert have reduced their holdings by more than 1%] Medicilon announced that as of July 10, 2026, shareholder Lin Changqing had reduced its holdings of 240,000 shares of the company through
July 13, 2026 at 8:58 AM
[1/4] 2026-07-13 16:37:19 - [Medicil: Shareholder Lin Changqing and persons acting in concert have reduced their holdings by more than 1%] Medicilon announced that as of July 10, 2026, shareholder Lin Changqing had reduced its holdings of 240,000 shares of the company through
2026-07-10 09:45:00 - [A-share CRO concept sector moved higher] Heyuan Biotech rose 16.00%, followed by Medicilon, Enox, Biocytogen, Baicheng Pharmaceutical, Asymchem, and Zhaoyan New Drug.
July 10, 2026 at 1:50 AM
2026-07-10 09:45:00 - [A-share CRO concept sector moved higher] Heyuan Biotech rose 16.00%, followed by Medicilon, Enox, Biocytogen, Baicheng Pharmaceutical, Asymchem, and Zhaoyan New Drug.
2026-07-10 10:00:01 - [A-share weight loss drug sector moved higher] Shuanglu Pharmaceutical hit the daily limit, and Lanxiao Technology, Medicilon, Zhengguang Shares, Changshan Pharmaceutical, Proton Shares, and Haofan Biotech followed the rise.
July 10, 2026 at 2:11 AM
2026-07-10 10:00:01 - [A-share weight loss drug sector moved higher] Shuanglu Pharmaceutical hit the daily limit, and Lanxiao Technology, Medicilon, Zhengguang Shares, Changshan Pharmaceutical, Proton Shares, and Haofan Biotech followed the rise.
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
July 9, 2026 at 2:21 AM
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
July 9, 2026 at 2:13 AM
[2/2] Chengdu Pioneer rising more than 10% intraday. Asymchem, Pharmaron, Medicilon, and Taiji Group all rose.
[2/2] Pharmaceutical, Saisheng Pharmaceutical, Shanghai RAAS, Medicilon, and Yuekang Pharmaceutical have followed suit.
July 8, 2026 at 1:50 AM
[2/2] Pharmaceutical, Saisheng Pharmaceutical, Shanghai RAAS, Medicilon, and Yuekang Pharmaceutical have followed suit.
[2/2] Pharmaceutical, Saisheng Pharmaceutical, Shanghai RAAS, Medicilon, and Yuekang Pharmaceutical have followed suit.
July 8, 2026 at 1:47 AM
[2/2] Pharmaceutical, Saisheng Pharmaceutical, Shanghai RAAS, Medicilon, and Yuekang Pharmaceutical have followed suit.
[2/2] Pharmaceutical, Saisheng Pharmaceutical, Shanghai RAAS, Medicilon, and Yuekang Pharmaceutical have followed suit.
July 8, 2026 at 1:45 AM
[2/2] Pharmaceutical, Saisheng Pharmaceutical, Shanghai RAAS, Medicilon, and Yuekang Pharmaceutical have followed suit.
2026-06-29 10:04:02 - [A-share medical services sector moved higher] Wanbang Pharmaceuticals and ST Zhongzhu hit the daily limit, while Biocytogen, Smart Pharmaceuticals, Pharmaron Chemicals, Medicilon, and Asymchem followed suit.
June 29, 2026 at 2:18 AM
2026-06-29 10:04:02 - [A-share medical services sector moved higher] Wanbang Pharmaceuticals and ST Zhongzhu hit the daily limit, while Biocytogen, Smart Pharmaceuticals, Pharmaron Chemicals, Medicilon, and Asymchem followed suit.
2026-06-29 10:04:01 - [A-share medical R&D outsourcing sector moved up due to sudden changes] Wanbang Pharmaceutical hit the daily limit, followed by Biocytogen, Smart Pharma, Pharmaron, Medicilon, Asymchem, and Yaoshi Technology.
June 29, 2026 at 2:18 AM
2026-06-29 10:04:01 - [A-share medical R&D outsourcing sector moved up due to sudden changes] Wanbang Pharmaceutical hit the daily limit, followed by Biocytogen, Smart Pharma, Pharmaron, Medicilon, Asymchem, and Yaoshi Technology.
2026-06-29 10:04:02 - [A-share medical services sector moved higher] Wanbang Pharmaceuticals and ST Zhongzhu hit the daily limit, while Biocytogen, Smart Pharmaceuticals, Pharmaron Chemicals, Medicilon, and Asymchem followed suit.
June 29, 2026 at 2:17 AM
2026-06-29 10:04:02 - [A-share medical services sector moved higher] Wanbang Pharmaceuticals and ST Zhongzhu hit the daily limit, while Biocytogen, Smart Pharmaceuticals, Pharmaron Chemicals, Medicilon, and Asymchem followed suit.
2026-06-29 10:04:01 - [A-share AI application (pharmaceutical and medical) sector moved up due to unusual changes] Biocytogen rose 15.77%, followed by Smart Medicine, Shutaishen, Hengrui Medicine, Medicilon, Yaoshi Technology, and Chengdu Pioneer.
June 29, 2026 at 2:13 AM
2026-06-29 10:04:01 - [A-share AI application (pharmaceutical and medical) sector moved up due to unusual changes] Biocytogen rose 15.77%, followed by Smart Medicine, Shutaishen, Hengrui Medicine, Medicilon, Yaoshi Technology, and Chengdu Pioneer.
[2/2] Pharmaceutical rose by more than 10%, Bailey Tianheng, Aileen, and Medicilon were among the top gainers.
June 25, 2026 at 6:30 AM
[2/2] Pharmaceutical rose by more than 10%, Bailey Tianheng, Aileen, and Medicilon were among the top gainers.